V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290005206 | 290006630 | 1.68 | 72.9 | Curative (C) | 2016-08-27 | 2016-09-11 | Capecitabine 42days + RT | N | Y | 290022566 | TRIAL |
| 290005207 | 290006630 | 1.67 | 94 | Palliative (P) | 2018-12-29 | 2018-12-29 | Carboplatin AUC 2 - 5 | N | N | 290022566 | CETUXIMAB + RT |
| 290005208 | 290003803 | 1.64 | 69.4 | Palliative (P) | 2018-02-10 | 2018-02-24 | Irinotecan + Modified De Gramont | N | N | 290022569 | TRIAL |
| 290005209 | 290003804 | null | null | Palliative (P) | 2016-12-30 | 2017-01-07 | Capecitabine + Cisplatin | N | N | 290022571 | CETUXIMAB |
| 290005210 | 290006631 | 1.74 | null | Palliative (P) | 2015-02-04 | 2015-02-06 | CETUXIMAB + IRINOTECAN + MDG | null | N | 290022572 | DABRAFENIB + TRAMETINIB |
| 290005211 | 290003805 | 1.73 | null | null | null | 2014-01-09 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290022574 | CISPLATIN + FLUOROURACIL |
| 290005212 | 290003806 | 1.66 | 85.4 | Neo-adjuvant (N) | 2014-09-19 | 2014-09-09 | Capecitabine | 02 | N | 290022576 | TRIAL |
| 290005213 | 290003807 | 1.55 | 72.2 | Palliative (P) | 2018-06-21 | 2018-07-11 | Capecitabine 35days + RT | 2 | N | 290022577 | CARBOPLATIN + RT |
| 290005214 | 290003808 | 1.74 | 0 | Adjuvant (A) | 2017-11-07 | 2017-11-07 | CAPECITABINE + RT | 02 | N | 290022579 | CAPECITABINE + RT |
| 290005215 | 290003808 | null | null | Curative (C) | 2017-06-20 | 2017-06-23 | CYTARABINE + DAUNORUBICIN | null | null | 290022579 | CETUXIMAB |
| 290005216 | 290003809 | null | 74.2 | Palliative (P) | 2016-04-13 | 2016-04-13 | CETUXIMAB + RT | 02 | N | 290022582 | IRINOTECAN + MDG |
| 290005217 | 290003810 | 1.76 | 88.2 | Palliative (P) | 2014-07-14 | 2014-07-14 | Trial Unspecified | 02 | N | 290022584 | CAPECITABINE + CISPLATIN |
| 290005218 | 290003810 | 1.79 | 112.8 | Curative (C) | 2014-10-11 | 2014-10-11 | PLATO Trials | 2 | N | 290022584 | CARBOPLATIN + RT |
| 290005219 | 290003810 | 1.71 | 55.1 | Palliative (P) | 2014-01-05 | 2014-02-14 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | N | 290022584 | CISPLATIN + FLUOROURACIL |
| 290005220 | 290003811 | 1.61 | null | Palliative (P) | 2017-04-07 | 2017-04-07 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290022595 | FCARBOST |
| 290005221 | 290003812 | 1.53 | 46.6 | Neo-adjuvant (N) | 2013-02-18 | 2013-03-18 | Capecitabine | N | N | 290022596 | CAPECITABINE + IRINOTECAN |
| 290005222 | 290003813 | 1.69 | 91.5 | null | 2015-09-08 | 2015-09-18 | OCTREOTIDE | N | N | 290022597 | LANREOTIDE |
| 290005223 | 290003814 | 0 | 0 | Palliative (P) | 2014-03-19 | 2014-03-25 | OCTREOTIDE | 02 | N | 290022601 | TRIAL |
| 290005224 | 290003815 | 1.47 | 49.6 | Palliative (P) | 2017-12-22 | 2017-12-23 | Streptozocin + MdG | 02 | N | 290022602 | GEMCITABINE |
| 290005225 | 290003816 | 1.55 | 48.9 | Adjuvant (A) | 2015-06-27 | 2015-07-02 | Cisplatin +Fluorouracil (3 wk) | N | N | 290022604 | CETUXIMAB + RT |
| 290005226 | 290003817 | null | 45.7 | Curative (C) | 2017-09-07 | 2017-09-07 | Cetuximab + Radiotherapy Load | 01 | Y | 290022605 | CAPECITABINE |
| 290005227 | 290003818 | 1.6 | 81.8 | null | 2015-11-08 | 2015-11-08 | EOX | 2 | N | 290022606 | CAPECITABINE + IRINOTECAN |
| 290005228 | 290003819 | 1.82 | 61.1 | Curative (C) | 2014-05-16 | 2014-05-16 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290022607 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005229 | 290003820 | null | 46 | Neo-adjuvant (N) | 2014-02-22 | 2014-03-04 | IRINOTECAN + MDG | N | N | 290022610 | CETUXIMAB + CISPLATIN + FU |
| 290005230 | 290006634 | 1.72 | 33.5 | Palliative (P) | 2014-12-14 | 2014-12-18 | CETUXIMAB + RT | 2 | null | 290022611 | CAPECITABINE |
| 290005231 | 290003821 | 1.7 | 83.1 | Curative (C) | 2015-11-02 | 2015-12-06 | CISPLATIN + FLUOROURACIL | N | Y | 290022612 | CAPECITABINE + RT |
| 290005232 | 290003822 | 1.68 | 83.6 | Palliative (P) | 2018-01-13 | 2018-01-16 | CARBOPLATIN + FLUOROURACIL | N | N | 290022613 | CAPECITABINE + RT |
| 290005233 | 290003822 | 1.7 | 77.8 | Palliative (P) | null | 2017-05-06 | Capecitabine + Cisplatin | N | N | 290022613 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005234 | 290003823 | 1.71 | 68 | Palliative (P) | 2015-04-23 | 2015-05-13 | Trial Unspecified | N | N | 290022619 | INTERFERON |
| 290005235 | 290003824 | null | null | Palliative (P) | 2014-01-08 | 2014-01-28 | Carbo F | N | N | 290022620 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005236 | 290003825 | 1.62 | 115.8 | Neo-adjuvant (N) | null | 2016-05-15 | Capecitabine | null | null | 290022622 | CAPECITABINE |
| 290005237 | 290003825 | 1.73 | 76.2 | Palliative (P) | null | 2015-04-25 | Capecitabine 35days + RT | N | N | 290022622 | TRIAL |
| 290005238 | 290003826 | 1.65 | null | Palliative (P) | 2016-12-06 | 2016-12-14 | CISPLATIN + ETOPOSIDE | 02 | N | 290022626 | CARBOPLATIN + RT |
| 290005239 | 290003827 | 1.68 | 44 | null | 2018-03-02 | 2018-03-24 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | null | 290022628 | FLUOROURACIL |
| 290005240 | 290003828 | 1.51 | 56 | Adjuvant (A) | 2017-04-19 | 2017-04-26 | CARBOPLATIN + RT | N | Y | 290022630 | CARBOPLATIN + ETOPOSIDE |
| 290005241 | 290003828 | 1.55 | 66.2 | Palliative (P) | 2014-03-04 | 2014-03-04 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | 290022630 | TRIAL |
| 290005242 | 290003829 | 1.78 | 42 | Disease modification (D) | 2013-09-17 | 2013-10-14 | Capecitabine (21days) + Carboplatin | N | N | 290022633 | CVP R |
| 290005243 | 290003829 | 1.57 | 53.1 | Adjuvant (A) | 2017-04-15 | 2017-04-27 | CARBOPLATIN + FLUOROURACIL | 02 | N | 290022633 | CAPECITABINE |
| 290005244 | 290003830 | 1.74 | 50 | Adjuvant (A) | 2015-10-02 | 2015-10-16 | LANREOTIDE | N | N | 290022639 | CAPECITABINE + RT |
| 290005245 | 290003831 | null | 89 | Adjuvant (A) | 2013-11-29 | 2013-12-18 | CHOP R - 21 days | 02 | null | 290022640 | FLUOROURACIL |
| 290005246 | 290003831 | null | null | Neo-adjuvant (N) | 2017-03-24 | 2017-03-27 | Carbo F | N | N | 290022640 | IRINOTECAN + MDG |
| 290005247 | 290007794 | 1.76 | 86 | Palliative (P) | 2014-12-13 | 2014-12-13 | Carboplatin AUC 2 - 5 | 02 | N | 290022643 | CARBOPLATIN + PACLITAXEL |
| 290005248 | 290003832 | 1.66 | null | Disease modification (D) | 2015-08-22 | 2015-09-05 | OCTREOTIDE | N | N | 290022645 | CETUXIMAB |
| 290005249 | 290006640 | 1.93 | null | Disease modification (D) | 2016-12-22 | 2016-12-26 | Irinotecan + Modified De Gramont | N | N | 290022646 | CETUXIMAB |
| 290005250 | 290007795 | 1.63 | 47 | Disease modification (D) | 2014-10-02 | 2014-10-09 | CAPECITABINE + TEMOZOLOMIDE | N | N | 290022648 | RITUXIMAB |
| 290005251 | 290003833 | 1.6 | 85.4 | Palliative (P) | 2015-01-02 | 2015-01-11 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290022649 | CARBOPLATIN + ETOPOSIDE |
| 290005252 | 290003834 | 1.63 | 66 | Disease modification (D) | 2013-08-28 | 2013-08-28 | PACLITAXEL | N | N | 290022651 | TRIAL |
| 290005253 | 290006641 | 1.64 | null | Palliative (P) | 2015-09-21 | 2015-09-21 | EOX | 02 | N | 290022652 | IBRUTINIB |
| 290005254 | 290003835 | 1.6 | 62.5 | Not known (9) | null | 2017-01-26 | DOXORUBICIN | null | null | 290022654 | IRINOTECAN + MDG |
| 290005255 | 290003836 | 1.59 | 45.5 | Palliative (P) | 2016-05-21 | 2016-05-21 | OCTREOTIDE | 02 | N | 290022655 | CAPECITABINE + RT |